FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

10956911000001107: Prandin 1mg tablets (Novo Nordisk Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
37514101000001111 Prandin 1mg tablets (Novo Nordisk Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
37514201000001116 Prandin 1mg tablets (Novo Nordisk Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prandin 1mg tablets (Novo Nordisk Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Prandin 1mg tablets (Novo Nordisk Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Prandin 1mg tablets (Novo Nordisk Ltd) Is a Product containing precisely repaglinide 1 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Prandin 1mg tablets (Novo Nordisk Ltd) Has active ingredient Repaglinide false Inferred relationship Existential restriction modifier
Prandin 1mg tablets (Novo Nordisk Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Prandin 1mg tablets (Novo Nordisk Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Prandin 1mg tablets (Novo Nordisk Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Prandin 1mg tablets (Novo Nordisk Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Prandin 1mg tablets (Novo Nordisk Ltd) Is a Prandin true Inferred relationship Existential restriction modifier
Prandin 1mg tablets (Novo Nordisk Ltd) Has specific active ingredient Repaglinide true Inferred relationship Existential restriction modifier
Prandin 1mg tablets (Novo Nordisk Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Prandin 1mg tablets (Novo Nordisk Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Prandin 1mg tablets (Novo Nordisk Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Prandin 1mg tablets (Novo Nordisk Ltd) 30 tablet 2 x 15 tablets Is pack of False Prandin 1mg tablets (Novo Nordisk Ltd) Inferred relationship Existential restriction modifier
Prandin 1mg tablets (Novo Nordisk Ltd) 90 tablet 6 x 15 tablets Is pack of False Prandin 1mg tablets (Novo Nordisk Ltd) Inferred relationship Existential restriction modifier
Prandin 1mg tablets (Novo Nordisk Ltd) 90 tablet 6 x 15 tablets Has AMP True Prandin 1mg tablets (Novo Nordisk Ltd) Inferred relationship Existential restriction modifier
Prandin 1mg tablets (Novo Nordisk Ltd) 30 tablet 2 x 15 tablets Has AMP True Prandin 1mg tablets (Novo Nordisk Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start